The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Karpov D.S.

Mental Health Research Center

Golimbet V.E.

Mental Health Research Center

Cellular and supracellular models in the study of molecular mechanisms associated with schizophrenia

Authors:

Karpov D.S., Golimbet V.E.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11): 46‑50

DOI: 10.17116/jnevro202212211146

Read: 2003 times

Download PDF (RU)
Contact the author
Table of contents

CELLULAR AND SUPRACELLULAR MODELS IN THE STUDY OF MOLECULAR MECHANISMS ASSOCIATED WITH SCHIZOPHRENIA
CELLULAR AND SUPRACELLULAR MODELS IN THE STUDY OF MOLECULAR MECHANISMS ASSOCIATED WITH SCHIZOPHRENIA

To cite this article:

Karpov DS, Golimbet VE. Cellular and supracellular models in the study of molecular mechanisms associated with schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11):46‑50. (In Russ.)
https://doi.org/10.17116/jnevro202212211146

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The asso­ciation of NOS1AP gene poly­morphisms with the dura­tion of the QT inte­rval in patients with schi­zophrenia receiving anti­psychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104
PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):28-34
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Clinical and psychopathological features of treatment-resistant schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50
Analysis of cognitive status in patients with different noso­logies and clinical variants of very late mani­festing schi­zophreniform psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):88-93
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Asso­ciation of cortisol levels with psychopathological features of depression and therapeutic response in female patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):45-54
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Legal regu­lation of the human genome editing technologies application: inte­rnational standards and the national practices. Russian Journal of Preventive Medi­cine. 2025;(10):7-15
Gene­tic predictors of the formation of placental insu­fficiency in patients with gestational diabetes mellitus without insu­lin requirement. Russian Journal of Human Reproduction. 2025;(5):103-110
Abstract:

Schizophrenia is a severe mental illness, in the etiology and pathogenesis of which hereditary factors make a significant contribution. Studies of the genetic causes of schizophrenia are conducted using a variety of models. This brief review introduces the reader to cellular and supracellular models that, because of their simplicity, low cost, and low labor intensity, help to effectively investigate the complex molecular mechanisms associated with schizophrenia. The potential of cellular and supracellular models is greatly enhanced by the use of the CRISPR/Cas9 genome editing technology. Genetically modified models make it possible to achieve a previously inaccessible depth and detail of understanding of the role of genetic factors in the onset and development of schizophrenia. The information obtained can be used in the design of new drugs for personalized treatment of schizophrenia patients.

Keywords:

schizophrenia
genes
causal variants
cell cultures
genome editing

Authors:

Karpov D.S.

Mental Health Research Center

Golimbet V.E.

Mental Health Research Center

Received:

05.04.2022

Accepted:

23.06.2022

Close metadata

References:

  1. Escudero I, Johnstone M. Genetics of Schizophrenia. Current Psychiatry Reports. 2014;16(11):502.  https://doi.org/10.1007/s11920-014-0502-8
  2. Baselmans BML, Yengo L, van Rheenen W, et al. Risk in Relatives, Heritability, SNP-Based Heritability, and Genetic Correlations in Psychiatric Disorders: A Review. Biol Psychiatry. 2021;89(1):11-19.  https://doi.org/10.1016/j.biopsych.2020.05.034
  3. Pardiñas AF, Holmans P, Pocklington AJ, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nature Genetics. 2018;50(3):381-389.  https://doi.org/10.1038/s41588-018-0059-2
  4. Statello L, Guo CJ, Chen LL, et al. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96-118.  https://doi.org/10.1038/s41580-020-00315-9
  5. Su XJ, Shen BD, Wang K, et al. Roles of the Neuron-Restrictive Silencer Factor in the Pathophysiological Process of the Central Nervous System. Front Cell Dev Biol. 2022;10:834620. https://doi.org/10.3389/fcell.2022.834620
  6. Noack F, Vangelisti S, Raffl G, et al. Multimodal profiling of the transcriptional regulatory landscape of the developing mouse cortex identifies Neurog2 as a key epigenome remodeler. Nat Neurosci. 2022;25(2):154-167.  https://doi.org/10.1038/s41593-021-01002-4
  7. Bigdeli TB, Fanous AH, Li Y, et al. Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans. Schizophr Bull. 2021;47(2):517-529.  https://doi.org/10.1093/schbul/sbaa133
  8. Schmidt-Kastner R, Guloksuz S, Kietzmann T, et al. Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain. Front Psychiatry. 2020;11:393.  https://doi.org/10.3389/fpsyt.2020.00393
  9. Dennison CA, Legge SE, Pardinas AF, et al. Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective. Schizophr Res. 2020;217:4-12.  https://doi.org/10.1016/j.schres.2019.10.048
  10. Dzirasa K, Covington III HE. Increasing the validity of experimental models for depression. Annals of the New York Academy of Sciences. 2012;1265(1):36-45.  https://doi.org/10.1111/j.1749-6632.2012.06669.x
  11. Abashkin DA, Kurishev AO, Karpov DS, Golimbet VE. Cellular Models in Schizophrenia Research. International Journal of Molecular Sciences. 2021;22(16):8518.
  12. Koszla O, Targowska-Duda KM, Kedzierska E, et al. In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia. Biomolecules. 2020;10(1). https://doi.org/10.3390/biom10010160
  13. Rasanen N, Tiihonen J, Koskuvi M, et al. The iPSC perspective on schizophrenia. Trends Neurosci. 2022;45(1):8-26.  https://doi.org/10.1016/j.tins.2021.11.002
  14. Page SC, Sripathy SR, Farinelli F, et al. Electrophysiological measures from human iPSC-derived neurons are associated with schizophrenia clinical status and predict individual cognitive performance. Proc Natl Acad Sci U S A. 2022;119(3). https://doi.org/10.1073/pnas.2109395119
  15. Simpson DJ, Olova NN, Chandra T. Cellular reprogramming and epigenetic rejuvenation. Clin Epigenetics. 2021;13(1):170.  https://doi.org/10.1186/s13148-021-01158-7
  16. Grubisha MJ, Sun X, MacDonald ML, et al. MAP2 is differentially phosphorylated in schizophrenia, altering its function. Mol Psychiatry. 2021;26(9):5371-5388. https://doi.org/10.1038/s41380-021-01034-z
  17. Zheng P, Su QP, Jin D, et al. Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor Overactivation in Striatal Neurons. Front Neurosci. 2020;14:642.  https://doi.org/10.3389/fnins.2020.00642
  18. Berdenis van Berlekom A, Muflihah CH, Snijders G, et al. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies. Schizophr Bull. 2020;46(2):374-386.  https://doi.org/10.1093/schbul/sbz060
  19. Zocher S, Kempermann G. Generation of mouse hippocampal neural precursor cell lines with CRISPR/Cas9-mediated gene knockouts. STAR Protoc. 2021;2(2):100472. https://doi.org/10.1016/j.xpro.2021.100472
  20. Gao Y, Gao K, Yang H. CRISPR/Cas: a potential gene-editing tool in the nervous system. Cell Regen. 2020;9(1):12.  https://doi.org/10.1186/s13619-020-00044-6
  21. Schrode N, Ho SM, Yamamuro K, et al. Synergistic effects of common schizophrenia risk variants. Nat Genet. 2019;51(10):1475-1485. https://doi.org/10.1038/s41588-019-0497-5
  22. Sundberg M, Pinson H, Smith RS, et al. 16p11.2 deletion is associated with hyperactivation of human iPSC-derived dopaminergic neuron networks and is rescued by RHOA inhibition in vitro. Nat Commun. 2021;12(1):2897. https://doi.org/10.1038/s41467-021-23113-z
  23. Li Y, Ma C, Li S, et al. Regulatory Variant rs2535629 in ITIH3 Intron Confers Schizophrenia Risk By Regulating CTCF Binding and SFMBT1 Expression. Adv Sci (Weinh). 2022;9(6):e2104786. https://doi.org/10.1002/advs.202104786
  24. Stachowiak EK, Benson CA, Narla ST, et al. Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1. Transl Psychiatry. 2017;7(11):6.  https://doi.org/10.1038/s41398-017-0054-x
  25. Mubarik A, Tohid H. Frontal lobe alterations in schizophrenia: a review. Trends Psychiatry Psychother. 2016;38(4):198-206.  https://doi.org/10.1590/2237-6089-2015-0088
  26. Notaras M, Lodhi A, Fang H, et al. The proteomic architecture of schizophrenia iPSC-derived cerebral organoids reveals alterations in GWAS and neuronal development factors. Transl Psychiatry. 2021;11(1):541.  https://doi.org/10.1038/s41398-021-01664-5
  27. Larrucea S, Butta N, Arias-Salgado EG, et al. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Exp Cell Res. 2008;314(10):2004-2015. https://doi.org/10.1016/j.yexcr.2008.03.009
  28. Persaud SD, Park SW, Ishigami-Yuasa M, et al. All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation. Sci Rep. 2016;6:22396. https://doi.org/10.1038/srep22396
  29. Xiang Y, Tanaka Y, Cakir B, et al. hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids. Cell Stem Cell. 2019;24(3):487-497e487. https://doi.org/10.1016/j.stem.2018.12.015
  30. Jiang Y, Patton MH, Zakharenko SS. A Case for Thalamic Mechanisms of Schizophrenia: Perspective From Modeling 22q11.2 Deletion Syndrome. Front Neural Circuits. 2021;15:769969. https://doi.org/10.3389/fncir.2021.769969
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.